VISN-wide BPA for point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25622N0241
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- -$7,335
Award facts
- Contract value 0% obligated
- $53,864.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,335 | |
| Original award | $61,200 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16) awarded a Blanket Purchase Agreement call to Roche Diagnostics Corporation for point-of-care whole blood glucose testing equipment and supplies, effective October 1, 2021, through September 30, 2022. The contract carries a ceiling value of $53,864.64 under a firm fixed-price structure with no set-aside designation, reflecting open competition. The contract is a child vehicle under Roche Diagnostics' parent General Services Administration Schedule contract for In Vitro Diagnostics, Reagents, Test (FSS-65-VII), which provides VISN 16 with pre-negotiated terms and pricing to support its point-of-care testing requirements. Performance will be executed from Roche Diagnostics' facility in Castleton, Indiana.
This award aligns with the Veterans Health Administration's broader diagnostic capabilities strategy. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, Indiana, holds an extensive federal contracting footprint across the VA system and Defense Health Agency, supplying advanced diagnostic solutions including molecular diagnostics, laboratory instruments, and point-of-care testing devices. The company maintains multiple active indefinite delivery contracts and blanket purchase agreements across numerous VISNs and military healthcare facilities, with contract values extending into the millions of dollars and terms extending through 2030. This specific VISN 16 award represents a smaller call against the GSA Schedule vehicle, supporting the network's operational needs for glucose monitoring capabilities within its healthcare facilities.
Quick answers
Who was awarded contract 36C25622N0241?
36C25622N0241 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2021.
How much is contract 36C25622N0241 worth?
The government has obligated -$7,335 on 36C25622N0241. Its current value, with exercised options, is $53,865.
Is contract 36C25622N0241 an order under another contract?
Yes. 36C25622N0241 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25622N0241 competed?
The extent of competition for 36C25622N0241 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award